BridgeBio Pharma (BBIO) Earnings Date & Reports

A.I. Advisor

published Earnings

BBIO is expected to report earnings to rise 59.22% to -93 cents per share on October 31

BridgeBio Pharma BBIO Stock Earnings Reports

Q3'24

Est.

$-0.94

Q2'24

Beat

by $0.41

Q1'24

Beat

by $0.72

Q4'23

Missed

by $0.09

Q3'23

Missed

by $0.29

The last earnings report on August 01 showed earnings per share of -58 cents, beating the estimate of -100 cents. With 1.84M shares outstanding, the current market capitalization sits at 4.69B.

View a ticker or compare two or three

Compare

BBIO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BBIO
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BBIO (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company which engages in developing transformative medicines to treat patients who suffer from mendelian diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

3160 Porter Drive

Phone

+1 650 391-9740

Employees

556

Web

https://www.bridgebio.com